Bergen, Norway,16 June 2022?-BerGenBioASA (OSE: BGBIO) (the "Company"), has been
notified that Anders Tullgren, Chairman of the Board and primary insider of
BerGenBio ASA, has bought 25,000 shares in BerGenBio ASA at an average price of
NOK 10.73 per share. The shares are purchased under the sign on bonus agreement
approved by the Extraordinary General Meeting 6 January 2022 in connection with
the appointment of Mr. Tullgren as Chairman of the Board in BerGenBio ASA.

After the transaction Mr. Tullgren holds 50,000 shares in BerGenBio ASA.

Please see the attached document for further details of the transaction.

Contact:

Martin Olin, CEO,BerGenBioASA
ir@bergenbio.com

RuneSkeie, CFO,BerGenBioASA
rune.skeie@bergenbio.com

This information issubject to the disclosure requirements pursuant to the EU
Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities
Trading Act.